SENP2 regulated the stability of β-catenin through WWOX in hepatocellular carcinoma cell

Tumor Biology

Volumn 35, Issue 10, 2014, Pages 9677-9682

  Jiang, Qing Feng ^a   Tian, Yu Wei ^a   Shen, Quan ^a   Xue, Huan Zhou ^a   Li, Ke ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Hepatocellular carcinoma cell; SENP2; SUMOylation; WWOX

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; CYSTEINE PROTEINASE; OXIDOREDUCTASE; SENP2 PROTEIN, HUMAN; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; WWOX PROTEIN, HUMAN;

GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

BETA CATENIN; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIVER NEOPLASMS; OXIDOREDUCTASES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84922391977     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2239-8     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. Maluccio M, Covey A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA: Cancer J Clin. 2012;62:394–9.
3. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol. 2007;8:947–56.
4. Wilkinson KA, Henley JM. Mechanisms, regulation and consequences of protein sumoylation. Biochem J. 2010;428:133–45.
5. Sarge KD, Park-Sarge OK. Sumo and its role in human diseases. Int Rev Cell Mol Biol. 2011;288:167–83.
6. Hwang KW, Won TJ, Kim H, Chun HJ, Chun T, Park Y. Characterization of the regulatory roles of the sumo. Diabetes Metab Res Rev. 2011;27:854–61.
7. Wei W, Yang P, Pang J, Zhang S, Wang Y, Wang MH, et al. A stress-dependent sumo4 sumoylation of its substrate proteins. Biochem Biophys Res Commun. 2008;375:454–9.
8. Wang CY, Podolsky R, She JX. Genetic and functional evidence supporting sumo4 as a type 1 diabetes susceptibility gene. Ann N Y Acad Sci. 2006;1079:257–67.
9. Hannoun Z, Greenhough S, Jaffray E, Hay RT, Hay DC. Post-translational modification by sumo. Toxicology. 2010;278:288–93.
10. Bawa-Khalfe T, Yeh ET. Sumo losing balance: sumo proteases disrupt sumo homeostasis to facilitate cancer development and progression. Genes Cancer. 2010;1:748–52.
11. Yeh ET. Sumoylation and de-sumoylation: wrestling with life’s processes. J Biol Chem. 2009;284:8223–7.
12. Kim JH, Baek SH. Emerging roles of desumoylating enzymes. Biochim Biophys Acta. 2009;1792:155–62.
13. Jiang M, Chiu SY, Hsu W. Sumo-specific protease 2 in mdm2-mediated regulation of p53. Cell Death Differ. 2011;18:1005–15.
14. Chiu SY, Asai N, Costantini F, Hsu W. Sumo-specific protease 2 is essential for modulating p53-mdm2 in development of trophoblast stem cell niches and lineages. PLoS Biol. 2008;6:e310.
15. Zhang XD, Goeres J, Zhang H, Yen TJ, Porter AC, Matunis MJ. Sumo −2/3 modification and binding regulate the association of cenp-e with kinetochores and progression through mitosis. Mol Cell. 2008;29:729–41.
16. Schweizer N, Ferras C, Kern DM, Logarinho E, Cheeseman IM, Maiato H. Spindle assembly checkpoint robustness requires tpr-mediated regulation of mad1/mad2 proteostasis. J Cell Biol. 2013;203:883–93.
17. Cubenas-Potts C, Goeres JD, Matunis MJ. Senp1 and Senp2 affect spatial and temporal control of sumoylation in mitosis. Mol Biol Cell. 2013;24:3483–95.
18. Lu H, Liu B, You S, Chen L, Dongmei Q, Gu M, Lu Y, Chen Y, Zhang F, Yu B: Senp2 regulates mef2a de-sumoylation in an activity dependent manner. Mol Biol Rep. 2012
19. Kang X, Qi Y, Zuo Y, Wang Q, Zou Y, Schwartz RJ, et al. Sumo-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. Mol Cell. 2010;38:191–201.
20. Shen HJ, Zhu HY, Yang C, Ji F. Senp2 regulates hepatocellular carcinoma cell growth by modulating the stability of beta-catenin. Asian Pac J Cancer Prev: APJCP. 2012;13:3583–7.
21. Tan MY, Mu XY, Liu B, Wang Y, Bao ED, Qiu JX, et al. Sumo-specific protease 2 suppresses cell migration and invasion through inhibiting the expression of mmp13 in bladder cancer cells. Cel Physiol Biochem: Int J Exp Cel Physiol, Biochem, Pharmacol. 2013;32:542–8.
22. Nait Achour T, Sentis S, Teyssier C, Philippat A, Lucas A, Corbo L, et al. Transcriptional repression of estrogen receptor alpha signaling by Senp2 in breast cancer cells. Mol Endocrinol (Baltim, Md). 2014;28:183–96.
23. Bouteille N, Driouch K, Hage PE, Sin S, Formstecher E, Camonis J, et al. Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein. Oncogene. 2009;28:2569–80.
24. Li YP, Wu CC, Chen WT, Huang YC, Chai CY. The expression and significance of WWOX and beta-catenin in hepatocellular carcinoma. APMIS: Acta Pathol, Microbiol, Immunol Scand. 2013;121:120–6.
25. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8:387–98.
26. Del Mare S, Kurek KC, Stein GS, Lian JB, Aqeilan RI. Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma. Am J Cancer Res. 2011;1:585–94.
27. Hezova R, Ehrmann J, Kolar Z. WWOX, a new potential tumor suppressor gene. Biomed Pap Med Fac Univ Palacky, Olomouc, Czechoslov. 2007;151:11–5.
28. Abdeen SK, Del Mare S, Hussain S, Remaileh MA, Salah Z, Hagan J, Rawahneh M, Pu XA, Russell S, Stein JL, Stein GS, Lian JB, Aqeilan RI: Conditional inactivation of the mouse wwox tumor suppressor gene recapitulates the null phenotype. J Cell Physiol. 2012
29. Aqeilan RI, Trapasso F, Hussain S, Costinean S, Marshall D, Pekarsky Y, et al. Targeted deletion of WWOX reveals a tumor suppressor function. Proc Natl Acad Sci USA. 2007;104:3949–54.